Moderna suffers setback in vaccine patent battle with Pfizer
Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...
Pfizer convinces US Patent Office to cancel two Moderna COVID-19 vaccine patents
Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U ...
Business Insider29d
Could Moderna’s (MRNA) 65% Stock Plunge Entice a Takeover?
While COVID-19 vaccine sales accounted for ... citing three key concerns. Firstly, Moderna’s second major revenue revision in six months has eroded confidence, making future forecasts less ...
MarketWatch27d
Moderna Swings to 4Q Loss After Early Launch of Updated Vaccine
Moderna swung to a loss in the last three months of the year after an early launch of its updated Covid-19 vaccine shifted sales out of the fourth quarter. The maker of the Spikevax Covid-19 ...
pharmaphorum1d
Moderna sues Pfizer/BioNTech over COVID-19 vaccine tech
The rivalry between Moderna and Pfizer/BioNTech ... as another mRNA COVID-19 vaccine developer – CureVac – filed a suit in Germany last month making similar allegations. Meanwhile, Alnylam ...
STAT28d
U.K. lawmaker wants regulators to probe pharma companies over ‘misleading’ Covid-19 vaccines statements
And the move comes after Moderna was chastised for the second time in five months by a U.K. trade group over its attempts to recruit children into a late-stage clinical trial for its Covid shot.